Taviss Pharma Private Limited
About Taviss Pharma Private Limited
Data last updated:
Taviss Pharma Private Limited is a private limited company based in Secunderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 26 February 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24232TG2014PTC093187. Its GSTIN is 36AAHFT7098N1Z8 (Telangana). The company holds 5 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Surekha Sadasivapet and Tharun Kande.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Secunderabad, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹52.82 Lakh, a growth of 24% compared to the previous year. For the same year it recorded a net profit of ₹1.34 Lakh (net margin 2.5%) and EBITDA of ₹1.58 Lakh (EBITDA margin 3%). Revenue has declined at a compounded annual rate (CAGR) of 18% over three years and 12% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Taviss Pharma has one previous CIN (Corporate Identification Number): U24232AP2014PTC093187. The current CIN is U24232TG2014PTC093187, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232TG2014PTC093187 | Current |
| U24232AP2014PTC093187 | Previous |
Contact details
Taviss Pharma Private Limited's registered office is in Secunderabad, Telangana. Its e-mail address is in the company report.
- Email
- Registered AddressHouse No. 02 – 133/2/66 Flat No 403 Sai Gautami Residency Spring Fields Je, Edimetla, Secunderabad, Telangana, India – 500055
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Taviss Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Taviss Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Taviss Pharma Private Limited, buy the company report.
Financials of Taviss Pharma Private Limited
FY 2025 filings availableTaviss Pharma Private Limited reported revenue of ₹52.82 Lakh (up 24% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 24% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 12%. EBITDA rose 61% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.58 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.34 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3% | ||||
| Net Profit Margin | 2.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Taviss Pharma Private Limited, buy the company report.
Board of directors of Taviss Pharma Private Limited
Taviss Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Surekha Sadasivapet | Director | 26 Feb 2014 | 12 Years 7 Months | Current |
| Tharun Kande | Additional Director | 24 Nov 2019 | 6 Years 10 Months | Current |
Peer comparison
Taviss Pharma Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Athanasius Pharma Private Limited | ₹53.12 Lakh (FY 2025) | -21.0% | Delhi, India | |||
| Amsky Pharma Private Limited | ₹53 Lakh (FY 2025) | 19.0% | Panchkula, Haryana, India | |||
| Axonav Pharma Private Limited | ₹52.98 Lakh (FY 2018) | -27.0% | Ghaziabad, Uttar Pradesh, India | |||
| Viti Healthcare Private Limited | ₹52.98 Lakh (FY 2025) | -19.0% | Haryana, India | |||
| Taviss Pharma Private Limitedthis company | ₹52.82 Lakh (FY 2024) | ₹1.34 Lakh | 2.5% | 24.0% | Secunderabad, Telangana, India |
To see the full peer comparison of Taviss Pharma Private Limited, buy the company report.
Auditor
Taviss Pharma Private Limited is audited by REVENUE & ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| REVENUE & ASSOCIATES | FY 2020 | 017835S |
Shareholding
The shareholding of Taviss Pharma Private Limited is on record for 5 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2019 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Taviss Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Taviss Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Taviss Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Taviss Pharma has 5 GST registrations: 2 active and 3 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAHFT7098N1Z8 | Telangana | Active | 01 Jul 2017 |
| 29AAHFT7098N2Z2 | Karnataka | Active | 04 May 2018 |
To see the full GST registrations and return filing status of Taviss Pharma Private Limited, buy the company report.
Recent activity
Taviss Pharma Private Limited has 3 board changes on record since 2014: 2 appointments and 1 cessation. The latest: Bhavani Tekula ceased to be Director on 25 Nov 2019.
Frequently asked questions
Taviss Pharma is an active private limited company based in Secunderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 26 February 2014 (12+ years old) and is registered under CIN U24232TG2014PTC093187.
Taviss Pharma has 2 current directors:
- Surekha Sadasivapet - Director
- Tharun Kande - Additional Director
The latest financial statements of Taviss Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Taviss Pharma is 36AAHFT7098N1Z8, registered in Telangana. The company has 5 GST registrations in all, of which 2 are active and 3 are cancelled or inactive. Other active GSTINs include 29AAHFT7098N2Z2 (Karnataka).
The CIN (Corporate Identification Number) of Taviss Pharma is U24232TG2014PTC093187. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Taviss Pharma was incorporated on 26 February 2014, making it 12+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Taviss Pharma by revenue are Athanasius Pharma Private Limited, Amsky Pharma Private Limited, Axonav Pharma Private Limited, Viti Healthcare Private Limited, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Bhavani Tekula ceased to be Director on 25 Nov 2019. Tharun Kande was appointed as Additional Director on 24 Nov 2019. Surekha Sadasivapet was appointed as Director on 26 Feb 2014.
The registered office of Taviss Pharma is at House No. 02 – 133266 Flat No 403 Sai Gautami Residency Spring Fields Je, Edimetla, Secunderabad, Telangana, India – 500055.
Taviss Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Taviss Pharma is compliant as of 11 August 2026. The company is actively filing with the Registrar of Companies.